Taken together, our results demonstrate that PKD-mediated CXCR4 internalization induced by BCR engagement in B-CLL is associated with lymph node enlargement and suggest PKD as a potential druggable target for CLL therapeutics. This evidence concerns the gene CXCR4 and B-cell chronic lymphocytic leukemia.